Logo image
Carbon monoxide releasing molecule-2 improves coagulation in patient plasma in vitro following cardiopulmonary bypass
Journal article   Peer reviewed

Carbon monoxide releasing molecule-2 improves coagulation in patient plasma in vitro following cardiopulmonary bypass

S. Nini Malayaman, John W. C. Entwistle, Percy Boateng, Andrew S. Wechsler, Joshua M. Persaud, Jack B. Cohen, James K. Kirklin and Vance G. Nielsen
Blood coagulation & fibrinolysis, v 22(5), pp 362-368
01 Jul 2011
PMID: 21346555

Abstract

Hematology Life Sciences & Biomedicine Science & Technology
The objective of the present study was to determine if a new procoagulant molecule, carbon monoxide releasing molecule (tricarbonyldichlororuthenium (II) dimer; CORM-2) would improve coagulation following cardiopulmonary bypass (CPB). Plasma was obtained from patients undergoing elective cardiac surgery requiring CPB. Whole blood was collected and anticoagulated with sodium citrate after induction of anesthesia and again after CPB and heparin neutralization with protamine. Blood samples were centrifuged for 15 min, with plasma collected and stored at -80 degrees C prior to analysis. Samples were subsequently exposed to 0 or 100 mu mol/l CORM-2, with coagulation activated with tissue factor. Data were collected with thrombelastography until clot strength stabilized. Patients underwent CPB for 133 +/- 61 min (mean +/- SD). The velocity of thrombus formation was significantly decreased (52%) by CPB, as was clot strength (53%). Addition of CORM-2 to plasma samples obtained after CPB significantly increased the velocity of clot formation (75%) and strength (52%) compared to matched unexposed samples. The lesion of plasmatic coagulation associated with CPB was significantly improved in vitro by addition of CORM-2. If preclinical assessments of efficacy and safety of CORM-2 are favorable, future clinical trials involving CORM-2 or other CORMs as a hemostatic intervention in the setting of CPB are justified. Blood Coagul Fibrinolysis 22: 362-368 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

Metrics

7 Record Views
2 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Hematology
Logo image